Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angina
Demand grows for CO2 laser angina therapy
October 27th, 2003
More cardiac surgeons are discovering the long-term benefits of carbon dioxide (CO2 ) Transmyocardial Laser Revascularization (TMR) therapy. The CO2 TMR therapy is a treatment for heart patients who suffer with severely debilitating angina. Emory Heart Center recently hosted its first CO2 TMR training program. Joseph Craver, a cardiac surgeon from The Emory Heart Center, directed the educational training seminar that included cardiac surgeons from leading cardiac centers throughout the United States. The CO2 TMR system is manufactured by PLC Systems, Inc., (PLC) and distributed by Edwards Lifesciences Corporation...
Source: Health & Medicine Week (2003-10-27)
|
